
Opinion|Videos|December 13, 2023
Introduction to Bispecific Antibodies: Operationalizing Administration and Follow-Up
Author(s)Justin LaPorte, PharmD, BCOP
Justin LaPorte, PharmD, BCOP, introduces the purpose and objectives for the program.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
4
Dr Tolaney on SG + Pembrolizumab Biomarker Data in First-Line mTNBC
5































